Compare Mutual Funds
Pros | Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | 5Y returns in the bottom 25% of the category. | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. |
INDMoney rank | 9/9 | 10/11 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 7 Years 9 Months | 14 Years | ||
Fund AUM | ₹99 Cr | ₹9166 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 1.37% | 1% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 27 | 40 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 2 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 97.53% | 97.3% | ||
Debt % | - | - | ||
P/E | 46.53 | 37.98 | ||
P/B | 6.06 | 5.6 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 7.34% | 8.35% | ||
3-Month Return | 2.33% | 3.22% | ||
6-Month Return | 12.99% | 9.83% | ||
1-Year Return | 18.04% | 16.1% | ||
3-Year Return | 21.89% | 18.88% | ||
5-Year Return | 14.26% | 15.31% |
Sharpe | 0.96 | 0.83 | ||
Alpha | 0.04 | -2.19 | ||
Beta | 0.95 | 0.89 | ||
Standard Deviation | 16.12 | 14.87 | ||
Information Ratio | -0.18 | -1.14 |
Description | LIC MF Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Sudhanshu Asthana, Dhaval Sangoi | Kinjal Desai, Amber Singhania, Sailesh Raj Bhan |

